# Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

> **NCT00009971** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 32 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** fenretinide

## Key facts

- **NCT ID:** NCT00009971
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2005-09
- **Final completion:** —
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00009971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00009971, "Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00009971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*